Dietary fatty acids and prevention of hormone-responsive cancer

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 224-233

  Rose, David P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; POLYUNSATURATED FATTY ACID;

ARACHIDONIC ACID METABOLISM; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; FAT INTAKE; HIGH RISK POPULATION; HORMONE RESPONSE; NONHUMAN; PROSTATE CANCER;

EID: 0030762252     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44172     Document Type: Article

References (131)

1. Cancer Statistics 1996. CA Cancer J Clin 46:5-27, 1996.
2. Chu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA, Edwards BK. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88:1571-1579, 1996.
3. Merrill RM, Potosky AL, Feuer EJ. Changing trends in U.S. prostate cancer incidence rates. J Natl Cancer Inst 88:1683-1685, 1996.
4. Eschwège P, Dumas F, Blanchet P, Le Maire V, Benoit G, Jardin A, Lacour B, Loric S. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 346:1528-1530, 1995.
5. Jordan VC. Chemosuppression of breast cancer with long-term tamoxifen therapy. Prev Med 20:3-14, 1991.
6. Brawley OW, Ford LG, Thompson I, Perlman JA, Kramer BS. 5-α-Reductase inhibition and prostate cancer prevention. Cancer Epidemiol Biomarkers Prev 3:177-182, 1994.
7. Dickson RB, Lippman ME. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endoer Rev 8:29-13, 1987.
8. Hodges CV. Hormone therapy of prostatic cancer. In: Rose DP, Ed. Endocrinology of Cancer. Boca Raton, FL: CRC Press, Vol 2:pp57-67, 1979.
9. Carter HB, Isaacs JT. Experimental and theoretical basis for hormonal treatment of prostatic cancer. Semin Urol 6:262-266, 1988.
10. Ennis BW, Valverius EM, Bates SE, Lippman ME, Bellot F, Kris R, Schlessinger J, Masui H, Goldenberg A, Mendelsohn J, Dickson RB. Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol Endocrinol 3:1830-1838, 1989.
11. Connolly JM, Rose DP. Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19:173-180, 1991.
12. Ethier SP. Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst 87:964-973, 1995.
13. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985.
14. Page DL, Dupont WD, Rogers LW. Ductal involvement by cells of atypical lobular hyperplasia in the breast: A long-term follow-up study of cancer risk. Hum Pathol 19:201-207, 1988.
15. Carter CL, Carle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467-477, 1988.
16. Nomura Y, Tashiro H, Katsuda Y. Benign breast disease as a breast cancer risk in Japanese women. Jpn J Cancer Res 84:938-944, 1993.
17. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6, 1990.
18. Weidner N. Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol 10:302-313, 1993.
19. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85:1045-1049, 1994.
20. Guinebretière J-ML, Monique G, Gavoille A, Bahi J. Angiogenesis and risk of breast cancer in women with fibrocystic disease. J Natl Cancer Inst 86:635-636, 1994.
21. Fregene TA, Kellogg CM, Pienta KJ. Microvessel quantitation as a measure of angiogenic activity in benign breast tissue lesions: A marker for precancerous disease? Int J Oncol 4:1199-1202, 1994.
22. Heffelfinger SC, Yassin R, Miller MA, Lower E. Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clin Cancer Res 2:1873-1878, 1996.
23. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 126:1130-1139, 1976.
24. Goodwin PJ, Boyd NF. Mammographic parenchymal pattern and breast cancer risk: A critical appraisal of the evidence. Am J Epidemiol 127:1097-1108, 1988.
25. Lee-Han H, Cooke G, Boyd NF. Quantitative evaluation of mammographic densities: A comparison of methods of assessment. Eur J Cancer Prev 4:285-292, 1995.
26. Boyd NF, Jensen HM, Cooke G, Lee Han H. Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst 84:1170-1179, 1992.
27. Page DL, Steel CM, Dixon JM. Carcinoma in situ and patients at high risk of breast cancer. Br Med J 310:39-42, 1995.
28. Hetelekidis S, Schnitt SJ, Morrow M. Harris JR. Management of ductal carcinoma in situ. CA Cancer J Clin 45:244-253, 1995.
29. Wynder EL, Mabuchi K, Whitmore WF Jr. Epidemiology of cancer of the prostate. Cancer 28:344-360, 1971.
30. Jackson MA, Ahluwalia BS, Herson J, Heshmat MY, Jackson AG, Jones GW, Kapoor SK, Kennedy J, Kovi J, Lucas AO, Nkposong EO, Olisa E, Williams AO. Characterization of prostatic carcinoma among blacks: A continuation report. Cancer Treat Rep 61:167-172, 1977.
31. Breslow N, Chan CW, Dhom G, Drury RAB, Franks LM, Gellei B, Lee YS, Lundberg S, Sharke B, Sternby NH, Tulinius H. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20:680-688, 1977.
32. Akazaki K, Stemmerman GN. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst 50:1137-1144, 1973.
33. Rose DP, Connolly JM. Dietary fat, fatty acids and prostate cancer. Lipids 27:798-803, 1992.
34. McNeal JE, Bostwick DG. Intraductal dysplasia: A premaligant lesion of the prostate. Human Pathol 17:64-71, 1986.
35. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59:788-794, 1987.
36. Brawer MK. Prostatic intraepithelial neoplasia: A premalignant lesion. J Cell Biochem 16G(Suppl):171-174, 1992.
37. Fudge K, Bostwick DG, Stearns ME. Platelet-derived growth factor A and B chains and the α and β receptors in prostatic intraepithelial neoplasia. Prostate 29:282-286, 1996.
38. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617-631, 1975.
39. Hems G. The contributions of diet and childbearing to breast cancer rates. Br J Cancer 37:974-982, 1978.
40. Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58:2363-2371, 1986.
41. Rose DP. Dietary fat and breast cancer: Controversy and biological plausibility. In: Weisburger EK, Ed. Diet and Breast Cancer. New York: Plenum Press, pp1-9, 1994.
42. Willett WC, Hunter DJ, Stampfer MJ, Colditz G, Manson JE, Spiegelman D, Rosner B, Hennekens CH, Speizer FE. Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA 268:2037-2044, 1992.
43. Howe GR, Friedenreich CM, Jain M, Miller AB. A cohort study of fat intake and risk of breast cancer. J Natl Cancer Inst 83:336-340, 1991.
44. Hunter DJ, Spiegelman D, Adami H-O, Beeson L, van den Brandt PA, Folsom AR, Fraser GE, Goldbohm A, Graham S, Howe GR, Kuski LH, Marshall JR, McDermott A, Miller AB, Speizer FE, Wolk A, Yaun S-S, Willett W. Cohort studies of fat intake and the risk of breast cancer - A pooled analysis. N Engl J Med 334:356-361, 1996.
45. Prentice RL, Sheppard L. Dietary fat and cancer: Consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1:81-97, 1990.
46. Hursting SD, Thornquist M, Henderson MM. Type of diet, fat and the incidence of cancer at five sites. Prev Med 19:242-253, 1990.
47. Sasaki S, Horacsek M, Kesteloot H. An ecological study of the relationship between dietary fat intake and breast cancer mortality. Prev Med 22:187-202, 1993.
48. Tominaga S, Kuroishi T. Epidemiology of breast cancer in Japan. Cancer Lett 90:75-79, 1995.
49. Hirayama T. Epidemiology of breast cancer with special reference to the role of diet. Prev Med 7:173-195, 1978.
50. Kato I, Tominaga S, Kuroishi T. Relationship between westernization of dietary habits and mortality from breast and ovarian cancers in Japan. Jpn J Cancer Res 78:349-357, 1987.
51. Lands WEM, Hamazaki T, Yamazaki K, Okuyama H, Sakai K, Goto Y, Hubbard VS. Changing dietary patterns. Am J Clin Nutr 51:991-993, 1990.
52. Goto Y. Changing trends in dietary habits and cardiovascular disease in Japan. An overview. Nutr Rev 50:398-401, 1992.
53. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: Increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 63:741-745, 1996.
54. Kamano K, Okuyama H, Konishi R, Nagasawa H. Effects of a high-linoleate and a high-α-linolenate diet on spontaneous mammary tumorigenesis in mice. Anticancer Res 9:1903-1908, 1989.
55. Slattery ML, O'Brien E, Mori M. Disease heterogeneity: Does it impact our ability to detect dietary associations with breast cancer? Nutr Cancer 24:213-220, 1995.
56. Lubin F, Way Y, Ron E, Black M, Chetrit A, Rosen N, Alfandary E, Modan B. Nutritional factors associated with benign breast disease etiology: A case-control study. Am J Clin Nutr 50:551-556, 1989.
57. Hislop TG, Band PR, Deschamps M, Ng V, Coldman AJ, Worth AJ, Labo T. Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 131:263-270, 1990.
58. Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 130:14-24, 1989.
59. Nordevang E, Azavedo E, Svane G, Nilsson B, Holm L-E. Dietary habits and mammographic patterns in patients with breast cancer. Breast Cancer Res Treat 26:207-215, 1993.
60. Tamura Y, Hirai A, Terano T, Yoshida S. Clinical and epidemiological studies of w-3 polyunsaturated fatty acids in Japan. In: Tanaka T, Okada A, Eds. Nutritional Support in Organ Failure. New York: Eisevier, pp89-95, 1990.
61. Dyerberg J, Bang HO. Hemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2:433-435, 1979.
62. Nobmann ED, Byers T, Lanier AP, Hankin JH, Jackson MY. The diet of Alaska Native adults: 1987-1988. Am J Clin Nutr 55:1024-1032, 1992.
63. Parkinson AJ, Cruz AL, Heyward WL, Bulkow LR, Hall D, Barstaed L, Connor WE. Elevated concentrations of plasma w-3 polyunsaturated fatty acids among Alaskan Eskimos. Am J Clin Nutr 59:384-388, 1994.
64. Lanier AP, Bulkow LR, Ireland B. Cancer in Alaskan Indians, Eskimos, and Aleuts, 1959-1983: Implications for etiology and control. Public Health Rep 104:658-664, 1989.
65. Kaizer L, Boyd NF, Kriukov V, Tritchler D. Fish consumption and breast cancer risk: An ecological study. Nutr Cancer 12:61-68, 1989.
66. Lanier AP, Kelly JJ, Smith B, Harpster AP, Tanttila H, Amadon C, Beckworth D, Key C, Davidson AM. Alaska Native cancer update: Incidence rates 1989-1993. Cancer Epidemiol Biomarkers Prev 5:749-751, 1996.
67. Rogers AE, Lee SY. Chemically-induced mammary gland tumors in rats: Modulation by dietary fat. In: Ip C, Birt DF, Rogers AE, Mettlin C, Eds. Dietary fat and cancer. New York: Alan R. Liss, pp255-282, 1986.
68. Welsch CW. Enhancement of mammary tumorigenesis by dietary fat: Review of potential mechanisms. Am J Clin Nutr 45:192-202, 1987.
69. Rose DP. Effects of dietary fatty acids on breast and prostate cancers: Evidence from in vitro experiments and animal studies. Am J Clin Nutr (in press).
70. Carroll KK, Hopkins GJ. Dietary polyunsaturated fat versus saturated fat in relation to mammary carcinogenesis. Lipids 14:155-158, 1979.
71. Cohen LA, Thompson DO, Maeura Y, Choi K, Blank ME, Rose DP. Dietary fat and mammary cancer. I. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis. J Natl Cancer Inst 77:33-42, 1986.
72. Tinsley IJ, Schmitz JA, Pierce DA. Influence of dietary fatty acids on the incidence of mammary tumors in the C3H mouse. Cancer Res 41:1460-1465, 1981.
73. Bandyopadhyay GK, Imagawa W, Wallace D, Nandi S. Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J Biol Chem 262:2750-2756, 1987.
74. Balakrishnan A, Cramer S, Bandyopadhyay GK, Imagawa W, Yang J, Elias J, Beattie CW, Das Gupta TK, Nandi S. Differential proliferative response to linoleate in cultures of epithelial cells from normal human breast and fibroadenomas. Cancer Res 49:857-862, 1989.
75. Welsch CW, Dehoog JV, O'Connor DH, Sheffield LG. Influence of dietary fat levels on development and hormone responsiveness of the mouse mammary gland. Cancer Res 45:6147-6157, 1985.
76. Zhang L, Bird RP, Bruce WR. Proliferative activity of murine mammary epithelium as affected by dietary fat and calcium. Cancer Res 47:4905-4908, 1987.
77. Xue L, Newmark H, Yang K, Lipkin M. Model of mouse mammary gland hyperproliferation and hyperplasia induced by a Western-style diet. Nutr Cancer 26:281-287, 1996.
78. Telang NT, Bockman RS, Sarkar NH. Fatty acid-induced modifications of mouse mammary alveolar lesions in organ culture. Carcinogenesis 5:1123-1127, 1984.
79. Telang NT. Fatty acid-induced modifications of mouse mammary epithelium as studied in an organ and cell culture system. In: Ip C, Birt DF, Rogers AE, Mettlin C, Eds. Dietary Fat and Cancer. New York: Alan R. Liss, pp707-728, 1986.
80. Telang NT, Basu A, Kurihara H, Osborne MP, Modak MJ. Modulation in the expression of murine mammary tumor virus, ras protooncogene, and of alveolar hyperplasia by fatty acids in mouse mammary explant cultures. Anticancer Res 8:971-976, 1988.
81. Hillyard LA, Abraham S. Effect of dietary polyunsaturated fatty acids on growth of mammary adenocarcinomas in mice and rats. Cancer Res 39:4430-4437, 1979.
82. Rose DP, Connolly JM, Meschter CL. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83:1491-1495, 1991.
83. Rose DP, Hatala MA, Connolly JM, Rayburn J. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res 53:4686-4690, 1993.
84. Rose DP, Connolly JM, Liu X-H. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice, and the invasive capacity of these cell lines in vitro. Cancer Res 54:6557-6562, 1994.
85. Jurkowski JJ, Cave WT Jr. Dietary effects of menhaden oil on the growth and membrane lipid composition of rat mammary tumors. J Natl Cancer Inst 74:1145-1150, 1985.
86. Karmali RA, Marsh J, Fuchs C. Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst 73:457-461, 1984.
87. Gabor H, Abraham S. Effect of dietary menhaden oil on tumor cell loss and accumulation of mass of a transplantable adenocarcinoma in BALB/c mice. J Natl Cancer Inst 76:1223-1229, 1986.
88. Kinoshita K, Noguchi M, Earashi M, Tanaka M, Sasaki T. Inhibitory effects of purified eicosapentaenoic acid and docosahexaenoic acid on growth and metastasis of murine transplantable mammary tumor. In Vivo 8:371-374, 1994.
89. Rose DP, Connolly JM. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastasis in nude mice. J Natl Cancer Inst 85:1743-1747, 1993.
90. Rose DP, Connolly JM, Rayburn J, Coleman M. Influence of diets containing different levels of eicosapentaenoic or docosahexaenoic acid on the growth and metastasis of human breast cancer cells in nude mice. J Natl Cancer Inst 87:587-592, 1995.
91. Rose DP, Connolly JM, Coleman M. Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res 2:1751-1756, 1996.
92. Carter CA, Milholland RJ, Shea W, Ip MM. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res 43:3559-3569, 1983.
93. Abou-El-Ela SH, Prasse KW, Carroll R, Wade AE, Dharwadkar S, Bunce OR. Eicosanoid synthesis in 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in Sprague-Dawley rats fed primrose oil, menhaden oil or corn oil. Lipids 23:948-954, 1988.
94. Abou-El-Ela SH, Prasse KW, Farrell RL, Carroll RW, Wade AE, Bunce OR. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res 49:1434-1440, 1989.
95. Noguchi M, Kitagawa H, Miyazaki I. Influence of esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz(a)anthracene in rats on high- and low-fat diets. Jpn J Cancer Res 84:1010-1014, 1993.
96. Tang DG, Chen YQ, Honn KV. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Natl Acad Sci USA 93:5241-5246, 1996.
97. Liu X-H, Connolly JM, Rose DP. The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acid-stimulated proliferation in vitro and enhanced growth in athymic nude mice. Cancer Lett 109:223-230, 1996.
98. Tang DG, Renaud C, Maher R, Dobrzynski P, Stojakovic S, Diglio CA, Honn KV. 12(S)-HETE is a physiological angiogenic factor. Proc Am Assoc Cancer Res 36:91, 1995.
99. Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J, Hagmann W. 12-Lipoxygenases and 12(S)-HETE: Role in cancer metastasis. Cancer Metastasis Rev 13:365-396, 1994.
100. Liu X-H, Connolly JM, Rose DP. Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line. Clin Exp Metastasis 14:145-152, 1996.
101. Osborne MP, Karmali RA, Hershcopf RJ, Bradlow HL, Kourides IA, Williams WR, Rosen PP, Fishman J. Omega-3 fatty acids: Modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Invest 6:629-632, 1988.
102. Gonzalez MJ, Schemmel RA, Gray JI, Dugan L, Sheffield LG, Welsch CW. Effect of dietary fat on growth of MCF-7 and MDA-MB-231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis 12:1231-1235, 1991.
103. Lands WEM. Biosynthesis of prostaglandins. Annu Rev Nutr 11:41-60, 1991.
104. Ferretti A, Judd JT, Marshall MW, Flanagan VP, Roman JM, Matusik EJ. Moderate changes in linoleate intake do not influence the systemic production of E prostaglandins. Lipids 20:268-272, 1985.
105. Boudreau MD, Chanmugam PS, Hart SB, Lee SH, Hwang DH. Lack of dose response by dietary n-3 fatty acids at a constant ratio of n-3 and n-6 fatty acids in suppressing eicosanoid biosynthesis from arachidonic acid. Am J Clin Nutr 54:111-117, 1991.
106. Cleland LG, James MJ, Neumann MA, D'Angelo M, Gibson RA. Linoleate inhibits EPA incorporation from dietary fish oil supplements in human subjects. Am J Clin Nutr 55:395-399, 1992.
107. 2 release in healthy subjects. Gastroenterology 105:1317-1322, 1993.
108. Bartram H-P, Gostner A, Reddy BS, Rao CV, Scheppach W, Dusel G, Richter A, Richter F, Kasper H. Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: Potential role of the n-3:n-6 fatty acid ratio. Eur J Cancer Prev 4:231-237, 1995.
109. Bairati I, Roy L, Meyer F. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease. Can J Cardiol 8:41-46, 1992.
110. Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. N Engl J Med 320:1037-1043, 1989.
111. Kremer JM. Clinical studies of omega-3 fatty acid supplementation in patients who have rheumatoid arthritis. Rheum Dis Clin North Am 17:391-402, 1991.
112. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 85:950-956, 1992.
113. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438-463, 1991.
114. Leaf A. Health claims: Omega-3 fatty acids and cardiovascular disease. Nutr Rev 50:150-154, 1992.
115. Landa M-C, Frago N, Tres A. Diet and the risk of breast cancer in Spain. Eur J Cancer Prev 3:313-320, 1994.
116. Martin-Moreno J-M, Willett WC, Gorgojo L, Banegas JR, Rodriguez-Artalejo F, Fernandez-Rodriguez JC, Maisonneuve P, Boyle P. Dietary fat, olive oil intake and breast cancer risk. Int J Cancer 58:774-780, 1994.
117. Trichopoulou A, Katsouyanni K, Stuver S, Tzala L, Gnardellis C, Rimm E, Trichopoulos D. Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst 87:110-116, 1995.
118. James MJ, Cleland LG, Gibson RA, Hawkes JS. Interaction between fish and vegetable oils in relation to rat leucocyte leukotriene production. J Nutr 121:631-637, 1991.
119. Greenwald P, Malone WF, Cerny ME, Stern HR. Cancer prevention research trials. Adv Cancer Res 61:1-23, 1993.
120. West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85-94, 1991.
121. Giovannucci EJ, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571-1579, 1993.
122. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86:281-286, 1994.
123. Mishina T, Watanabe H, Araki H, Nakao M. Epidemiological study of prostatic cancer by match-pair analysis. Prostate 6:423-436, 1985.
124. Ewings P, Bowie C. A case-control study of cancer of the prostate in Somerset and East Devon. Br J Cancer 74:661-666, 1996.
125. Godley PA, Campbell MK, Gallagher P, Martinson FEA, Mohler JL, Sandier RS. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomarkers Prev 5:115-119, 1996.
126. Wynder EL, Rose DP, Cohen LA. Nutrition and prostate cancer: A proposal for dietary intervention. Nutr Cancer 22:1-10, 1994.
127. Karmali RA, Reichel P, Cohen LA, Terano T, Hirai A, Tamura Y, Yoshida S. The effects of dietary w-3 fatty acids on the DU-145 transplantable human prostatic tumor. Anticancer Res 17:1173-1180, 1987.
128. Rose DP, Cohen LA. Effects of dietary menhaden oil and retinyl acetate on the growth of DU145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis 9:603-605, 1988.
129. Rose DP, Connolly JM. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18:243-254, 1991.
130. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WDW. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87:1456-1462, 1995.
131. Wynder EL, Fair WR. Prostate cancer - Nutrition adjunct therapy. (editorial) J Urol 156:1364-1365, 1996.